Digraph
Organize the world
Digraph
Search
Everything
This topic
Blog
Recent
Everything
Sign in
Exebacase
Exebacase
Execabase
CF-301
Parent topics
Contrafect
New and investigational antibiotics
This topic
Recent activity
You must be
signed in
to add and move topics and links.
Exebacase Gains Breakthrough Therapy Status for MRSA Bacteremia
https://www.empr.com/home/news/drugs-in-the-pipeline/exebacase-gains-breakthrough-therapy-status-for-mrsa-bacteremia-including-right-sided-endocarditis/
Exebacase
FDA grants ‘breakthrough’ status to antibiotic alternative as ContraFect rushes to join fight against superbug – Endpoints News
https://endpts.com/fda-grants-breakthrough-status-to-antibiotic-alternative-as-contrafect-rushes-to-join-fight-against-superbug/
Exebacase
Lysins Unlimited: Phages’ Secret Weapon
https://www.genengnews.com/insights/lysins-unlimited-phages-secret-weapon/
Contrafect
Exebacase
Graham Hatfull
Lumen
Use of bacteriophages to treat antibiotic-resistant infections
Use of phages to treat Isabelle Holdaway
Stewardship / Resistance Scan for Feb 24, 2020 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2020/02/stewardship-resistance-scan-feb-24-2020
Exebacase
Penicillin antibiotics
The Virtuous Side of Viruses - Scientific American
https://www.scientificamerican.com/article/the-virtuous-side-of-viruses/
Exebacase
Overviews of the use of phage therapy to treat antibiotic-resistant infections
Use of phages to treat Tom Patterson